BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 32561481)

  • 1. PDGFRβ plays an essential role in patient vitreous-stimulated contraction of retinal pigment epithelial cells from epiretinal membranes.
    Yang Y; Huang X; Ma G; Cui J; Matsubara JA; Kazlauskas A; Zhao J; Wang J; Lei H
    Exp Eye Res; 2020 Aug; 197():108116. PubMed ID: 32561481
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ligand-independent activation of platelet-derived growth factor receptor β promotes vitreous-induced contraction of retinal pigment epithelial cells.
    Duan Y; Wu W; Cui J; Matsubara JA; Kazlauskas A; Ma G; Li X; Lei H
    BMC Ophthalmol; 2023 Aug; 23(1):344. PubMed ID: 37537538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PDGF receptors are activated in human epiretinal membranes.
    Cui J; Lei H; Samad A; Basavanthappa S; Maberley D; Matsubara J; Kazlauskas A
    Exp Eye Res; 2009 Mar; 88(3):438-44. PubMed ID: 19032953
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitory effects of resveratrol on PDGF-BB-induced retinal pigment epithelial cell migration via PDGFRβ, PI3K/Akt and MAPK pathways.
    Chan CM; Chang HH; Wang VC; Huang CL; Hung CF
    PLoS One; 2013; 8(2):e56819. PubMed ID: 23457620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Idelalisib inhibits vitreous-induced Akt activation and proliferation of retinal pigment epithelial cells from epiretinal membranes.
    Xin T; Han H; Wu W; Huang X; Cui J; Matsubara JA; Song J; Wang F; Colyer M; Lei H
    Exp Eye Res; 2020 Jan; 190():107884. PubMed ID: 31786159
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A potential role for PDGF-C in experimental and clinical proliferative vitreoretinopathy.
    Lei H; Hovland P; Velez G; Haran A; Gilbertson D; Hirose T; Kazlauskas A
    Invest Ophthalmol Vis Sci; 2007 May; 48(5):2335-42. PubMed ID: 17460299
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vitreous M2 Macrophage-Derived Microparticles Promote RPE Cell Proliferation and Migration in Traumatic Proliferative Vitreoretinopathy.
    Song Y; Liao M; Zhao X; Han H; Dong X; Wang X; Du M; Yan H
    Invest Ophthalmol Vis Sci; 2021 Sep; 62(12):26. PubMed ID: 34554178
    [TBL] [Abstract][Full Text] [Related]  

  • 8. P38 inhibition reverses TGFβ1 and TNFα-induced contraction in a model of proliferative vitreoretinopathy.
    Schiff L; Boles NC; Fernandes M; Nachmani B; Gentile R; Blenkinsop TA
    Commun Biol; 2019; 2():162. PubMed ID: 31069271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epithelial Membrane Protein-2 in Human Proliferative Vitreoretinopathy and Epiretinal Membranes.
    Telander DG; Yu AK; Forward KI; Morales SA; Morse LS; Park SS; Gordon LK
    Invest Ophthalmol Vis Sci; 2016 Jun; 57(7):3112-7. PubMed ID: 27294805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphoinositide 3-kinase δ inactivation prevents vitreous-induced activation of AKT/MDM2/p53 and migration of retinal pigment epithelial cells.
    Han H; Chen N; Huang X; Liu B; Tian J; Lei H
    J Biol Chem; 2019 Oct; 294(42):15408-15417. PubMed ID: 31467081
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombin induces epithelial-mesenchymal transition and collagen production by retinal pigment epithelial cells via autocrine PDGF-receptor signaling.
    Bastiaans J; van Meurs JC; van Holten-Neelen C; Nagtzaam NM; van Hagen PM; Chambers RC; Hooijkaas H; Dik WA
    Invest Ophthalmol Vis Sci; 2013 Dec; 54(13):8306-14. PubMed ID: 24302586
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive circular RNA profiling of proliferative vitreoretinopathy and its clinical significance.
    Yao J; Hu LL; Li XM; Shan K; Zhou RM; Ge HM; Yao MD; Jiang Q; Zhao C; Yan B
    Biomed Pharmacother; 2019 Mar; 111():548-554. PubMed ID: 30597308
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Robo1 on retinal pigment epithelial cells and experimental proliferative vitreoretinopathy.
    Huang L; Xu Y; Yu W; Li Y; Chu L; Dong J; Li X
    Invest Ophthalmol Vis Sci; 2010 Jun; 51(6):3193-204. PubMed ID: 20071679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble EphB4 inhibition of PDGF-induced RPE migration in vitro.
    He S; Kumar SR; Zhou P; Krasnoperov V; Ryan SJ; Gill PS; Hinton DR
    Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):543-52. PubMed ID: 19696168
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective Effects of Fucoidan on Epithelial-Mesenchymal Transition of Retinal Pigment Epithelial Cells and Progression of Proliferative Vitreoretinopathy.
    Zhang Y; Zhao D; Yang S; Yao H; Li M; Zhao C; Zhang J; Xu GT; Li H; Wang F
    Cell Physiol Biochem; 2018; 46(4):1704-1715. PubMed ID: 29698960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The effect of platelet-derived growth factor on the formation of proliferative vitreoretinopathy].
    Liang Y; Li X; Fan J; Zhao M; Jiang Y
    Zhonghua Yan Ke Za Zhi; 2002 Mar; 38(3):144-7. PubMed ID: 11955317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet-derived growth factor ligands and receptors immunolocalized in proliferative retinal diseases.
    Robbins SG; Mixon RN; Wilson DJ; Hart CE; Robertson JE; Westra I; Planck SR; Rosenbaum JT
    Invest Ophthalmol Vis Sci; 1994 Sep; 35(10):3649-63. PubMed ID: 8088954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Methotrexate on an In Vitro Patient-Derived Model of Proliferative Vitreoretinopathy.
    Amarnani D; Machuca-Parra AI; Wong LL; Marko CK; Stefater JA; Stryjewski TP; Eliott D; Arboleda-Velasquez JF; Kim LA
    Invest Ophthalmol Vis Sci; 2017 Aug; 58(10):3940-3949. PubMed ID: 28777835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth factors outside the PDGF family drive experimental PVR.
    Lei H; Velez G; Hovland P; Hirose T; Gilbertson D; Kazlauskas A
    Invest Ophthalmol Vis Sci; 2009 Jul; 50(7):3394-403. PubMed ID: 19324843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of DNA Methylation and Methyl-CpG-Binding Protein 2 Suppresses RPE Transdifferentiation: Relevance to Proliferative Vitreoretinopathy.
    He S; Barron E; Ishikawa K; Nazari Khanamiri H; Spee C; Zhou P; Kase S; Wang Z; Dustin LD; Hinton DR
    Invest Ophthalmol Vis Sci; 2015 Aug; 56(9):5579-89. PubMed ID: 26305530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.